Your browser doesn't support javascript.
loading
Gemcitabine plus nab-paclitaxel for pancreatic cancer and interstitial lung disease: A nationwide longitudinal study.
Saito, Kei; Michihata, Nobuaki; Hamada, Tsuyoshi; Jo, Taisuke; Matsui, Hiroki; Fushimi, Kiyohide; Nakai, Yousuke; Yasunaga, Hideo; Fujishiro, Mitsuhiro.
Affiliation
  • Saito K; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Michihata N; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan.
  • Hamada T; Department of Health Services Research, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Jo T; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Matsui H; Department of Hepato-Biliary-Pancreatic Medicine, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Fushimi K; Department of Health Services Research, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Nakai Y; Department of Respiratory Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Yasunaga H; Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Tokyo, Japan.
  • Fujishiro M; Department of Health Informatics and Policy, Graduate School of Medicine, Tokyo Medical and Dental University, Tokyo, Japan.
Cancer Sci ; 114(10): 3996-4005, 2023 Oct.
Article in En | MEDLINE | ID: mdl-37547944
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Cancer Sci Year: 2023 Type: Article Affiliation country: Japan
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Cancer Sci Year: 2023 Type: Article Affiliation country: Japan